BSE Live
Apr 20, 16:01Prev. Close
29.75
Open Price
29.24
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 20, 15:15Prev. Close
29.89
Open Price
0.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
31.97 (1)
| Balance Sheet of Mangalam Drugs & Organics (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 | |
| Total Share Capital | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 | |
| Reserves and Surplus | 132.83 | 126.52 | 136.13 | 134.73 | 115.13 | |
| Total Reserves and Surplus | 132.83 | 126.52 | 136.13 | 134.73 | 115.13 | |
| Total Shareholders Funds | 148.66 | 142.35 | 151.96 | 150.56 | 130.96 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 9.23 | 13.35 | 18.77 | 25.10 | 6.88 | |
| Deferred Tax Liabilities [Net] | 9.82 | 12.09 | 14.52 | 13.49 | 14.18 | |
| Other Long Term Liabilities | 6.80 | 8.41 | 9.03 | 9.15 | 3.19 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 25.84 | 33.85 | 42.32 | 47.75 | 24.25 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 71.94 | 74.60 | 49.57 | 47.10 | 51.18 | |
| Trade Payables | 91.32 | 83.05 | 97.07 | 54.55 | 42.68 | |
| Other Current Liabilities | 20.38 | 22.31 | 17.37 | 25.20 | 13.38 | |
| Short Term Provisions | 1.10 | 0.99 | 1.34 | 3.27 | 0.40 | |
| Total Current Liabilities | 184.74 | 180.95 | 165.36 | 130.11 | 107.64 | |
| Total Capital And Liabilities | 359.24 | 357.14 | 359.63 | 328.43 | 262.85 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 126.38 | 126.52 | 127.15 | 126.62 | 109.52 | |
| Intangible Assets | 29.14 | 20.78 | 15.21 | 8.35 | 8.47 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 6.40 | 0.18 | 6.35 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 158.21 | 155.04 | 151.85 | 140.67 | 124.35 | |
| Non-Current Investments | 0.03 | 0.03 | 0.00 | 0.00 | 0.22 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 2.01 | 2.29 | 1.19 | 5.28 | 6.30 | |
| Total Non-Current Assets | 160.25 | 157.36 | 153.04 | 145.96 | 130.87 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 138.80 | 123.64 | 137.47 | 117.11 | 58.59 | |
| Trade Receivables | 39.07 | 27.94 | 46.53 | 46.49 | 53.59 | |
| Cash And Cash Equivalents | 2.57 | 1.01 | 2.69 | 1.95 | 0.59 | |
| Short Term Loans And Advances | 1.09 | 1.17 | 0.05 | 0.04 | 0.01 | |
| OtherCurrentAssets | 17.44 | 46.02 | 19.85 | 16.88 | 19.20 | |
| Total Current Assets | 198.99 | 199.78 | 206.58 | 182.47 | 131.98 | |
| Total Assets | 359.24 | 357.14 | 359.63 | 328.43 | 262.85 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 34.64 | 11.96 | 26.33 | 6.26 | 9.61 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 63.48 | 87.01 | 95.82 | 214.79 | 150.60 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 1.22 | 0.89 | 1.98 | 0.23 | 0.07 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 187.39 | 168.93 | -- | -- | -- | |
| Other Earnings | -- | -- | 107.82 | 140.65 | 142.13 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.57 | 5.57 | 5.57 | 5.57 | 5.57 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.03 | 0.03 | 0.00 | 0.00 | 0.11 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
20.01.2026
Mangalam Drugs Consolidated December 2025 Net Sales at Rs 58.49 crore, down 34.07% Y-o-Y
20.01.2026
Mangalam Drugs Standalone December 2025 Net Sales at Rs 58.49 crore, down 34.07% Y-o-Y
25.11.2025
Mangalam Drugs Consolidated September 2025 Net Sales at Rs 49.54 crore, down 38.03% Y-o-Y
24.11.2025
Mangalam Drugs Standalone September 2025 Net Sales at Rs 49.54 crore, down 38.03% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth